OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma
Timothy P. DiPeri, Ming Zhao, Kurt W. Evans, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 2, pp. 322-334
Closed Access | Times Cited: 13
Timothy P. DiPeri, Ming Zhao, Kurt W. Evans, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 2, pp. 322-334
Closed Access | Times Cited: 13
Showing 13 citing articles:
Understanding and Overcoming Resistance to Selective FGFR inhibitors Across FGFR2-Driven Malignancies
Francesco Facchinetti, Yohann Loriot, Floriane Brayé, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 21, pp. 4943-4956
Open Access | Times Cited: 9
Francesco Facchinetti, Yohann Loriot, Floriane Brayé, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 21, pp. 4943-4956
Open Access | Times Cited: 9
RAS signaling in carcinogenesis, cancer therapy and resistance mechanisms
Xiaojuan Yang, Hong Wu
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 6
Xiaojuan Yang, Hong Wu
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 6
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors
Benjamin Garmezy, Mitesh J. Borad, Rastilav Bahleda, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 4, pp. 1165-1173
Open Access | Times Cited: 5
Benjamin Garmezy, Mitesh J. Borad, Rastilav Bahleda, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 4, pp. 1165-1173
Open Access | Times Cited: 5
Genomic correlates of response and resistance to the irreversible FGFR1-4 inhibitor futibatinib based on biopsy and circulating tumor DNA profiling
Lipika Goyal, Daniel DiToro, Antoine Hollebecque, et al.
Annals of Oncology (2024)
Closed Access | Times Cited: 5
Lipika Goyal, Daniel DiToro, Antoine Hollebecque, et al.
Annals of Oncology (2024)
Closed Access | Times Cited: 5
A Model for Decoding Resistance in Precision Oncology: Acquired Resistance to FGFR inhibitors in Cholangiocarcinoma
Love Goyal, Daniel DiToro, Francesco Facchinetti, et al.
Annals of Oncology (2024)
Open Access | Times Cited: 5
Love Goyal, Daniel DiToro, Francesco Facchinetti, et al.
Annals of Oncology (2024)
Open Access | Times Cited: 5
Case Report: FGFR2 inhibitor resistance via PIK3CA and CDKN2A/B in an intrahepatic cholangiocarcinoma patient with FGFR2-SH3GLB1 fusion
Nadja Ballin, A. Ott, Olga Seibel-Kelemen, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Nadja Ballin, A. Ott, Olga Seibel-Kelemen, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Oncogenic Signalling Pathways in Cancer Immunotherapy: Leader or Follower in This Delicate Dance?
Douglas Cartwright, Andrew Kidd, Sonam Ansel, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4393-4393
Open Access
Douglas Cartwright, Andrew Kidd, Sonam Ansel, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4393-4393
Open Access
Precision Oncology in Hepatopancreatobiliary Cancer Surgery
Timothy E. Newhook, Susan Tsai, Funda Meric‐Bernstam
Surgical Oncology Clinics of North America (2024) Vol. 33, Iss. 2, pp. 343-367
Closed Access | Times Cited: 2
Timothy E. Newhook, Susan Tsai, Funda Meric‐Bernstam
Surgical Oncology Clinics of North America (2024) Vol. 33, Iss. 2, pp. 343-367
Closed Access | Times Cited: 2
Cholangiocarcinoma Targeted Therapies: Mechanisms of Action and Resistance
Haley Ellis, Chiara Braconi, Juan W. Valle, et al.
American Journal Of Pathology (2024)
Closed Access | Times Cited: 2
Haley Ellis, Chiara Braconi, Juan W. Valle, et al.
American Journal Of Pathology (2024)
Closed Access | Times Cited: 2
Apoptosis, MAPK signaling pathway affected in tilapia liver following nano-microplastics and sulfamethoxazole acute co-exposure
Yao Zheng, Jiajia Li, Jiancao Gao, et al.
Comparative Biochemistry and Physiology Part D Genomics and Proteomics (2024) Vol. 53, pp. 101370-101370
Closed Access | Times Cited: 1
Yao Zheng, Jiajia Li, Jiancao Gao, et al.
Comparative Biochemistry and Physiology Part D Genomics and Proteomics (2024) Vol. 53, pp. 101370-101370
Closed Access | Times Cited: 1
Targeted therapies in biliary tract cancer—when precision becomes imprecise
Colm J. O’Rourke, Jakob Vasehus Schou, Jesper B. Andersen, et al.
ESMO Gastrointestinal Oncology (2024) Vol. 5, pp. 100085-100085
Open Access
Colm J. O’Rourke, Jakob Vasehus Schou, Jesper B. Andersen, et al.
ESMO Gastrointestinal Oncology (2024) Vol. 5, pp. 100085-100085
Open Access
Neoadjuvant Pemigatinib as a Bridge to Living Donor Liver Transplantation for Intrahepatic Cholangiocarcinoma with FGFR2 Rearrangement
Matthew Byrne, Richard F. Dunne, Jennifer I. Melaragno, et al.
American Journal of Transplantation (2024)
Closed Access
Matthew Byrne, Richard F. Dunne, Jennifer I. Melaragno, et al.
American Journal of Transplantation (2024)
Closed Access
New Relevant Evidence in Cholangiocarcinoma Biology and Characterization
N. M. Porro, Elena Spínola-Lasso, Mirella Pastore, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4239-4239
Open Access
N. M. Porro, Elena Spínola-Lasso, Mirella Pastore, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4239-4239
Open Access
Systemic approaches in biliary tract cancers: a review in the era of multidirectional precision medicine
Cha Len Lee, Anna Saborowski, Arndt Vogel
Expert Opinion on Pharmacotherapy (2024)
Closed Access
Cha Len Lee, Anna Saborowski, Arndt Vogel
Expert Opinion on Pharmacotherapy (2024)
Closed Access
